Vitamin D3 for Life

Live Enlightened

Physiology

Paracrine Vitamin D Signalling: Study Summary

Previous related pageParacrine Vitamin D Signalling: Full StudyNext related pageParacrine Vitamin D Signalling: Full Study
Study at a glance

What is the short answer?

Some laboratory experiments show that cells making active vitamin D can change responses in nearby cells. The result depends on the cells, their treatment and access to the starting vitamin D compound. Responding cells can also make active vitamin D themselves.

Who or what was studied?

Researchers studied human immune cells grown in the laboratory and specially altered mice. They did not test whether supplements improved health in people.

What changed the response?

Timing and the way cells were stimulated mattered. A protein that carries vitamin D compounds in blood limited some cell responses to the starting compound. Mouse experiments showed that similar blood hormone levels can occur despite changes in kidney-related metabolism and other body measurements.

What does this mean, and what remains uncertain?

The starting vitamin D compound supplied in blood, local production and breakdown must be considered together. A blood level cannot describe every tissue response. These studies do not establish activity in every tissue, a general health benefit or a personal dose. They did not measure how much hormone each human tissue makes or uses over time.

Read the full article below ↓

Some cells can make active vitamin D and change responses in nearby cells in laboratory experiments. The result depends on the cells, how they were stimulated and access to the starting vitamin D compound. Mouse studies add information about local production and kidney control. These findings support local communication under the tested conditions. They do not show a health benefit from supplements in people. Paracrine Vitamin D Signalling: Full Study

How was communication between cells tested?

The studies distinguish 25-hydroxyvitamin D, the starting compound carried in blood, from calcitriol, the active vitamin D hormone. A cell may respond to active hormone supplied directly without being able to make enough from the starting compound. Finding an enzyme that performs this conversion is not the same as showing that hormone was made and changed a nearby cell.

Jeffery and colleagues transferred fluid from human dendritic cells to separately stimulated T cells. Both are immune-cell types. The responding T cells increased CTLA-4, a protein involved in controlling T-cell responses. Other tests supported conversion of the starting compound into active hormone. This supports communication from producing cells to other cells in those laboratory conditions. It did not trace every hormone molecule or measure a health benefit.

Villalba Lopez and colleagues studied macrophages, another immune-cell type. Macrophages prepared under different laboratory conditions made different amounts of active hormone and changed responses in T cells grown with them. These cell categories do not represent every macrophage in a living tissue. Other substances released by cells can affect their neighbours, so not every response to transferred fluid can be assigned to calcitriol alone.

What can change the response?

Vitamin D-binding protein carries vitamin D compounds in blood. Adding this protein limited several cell responses to the starting compound. Some macrophage cultures remained active at the tested concentration. However, the highest tested concentration was below the usual concentration in blood. The experiment did not show that they could overcome the usual amount of carrier binding in blood.

Kongsbak and colleagues found that stimulated T cells developed the ability to make active hormone over several days. Chauss and colleagues linked a particular T-cell response to local vitamin D processing. Responding cells can therefore contribute their own active hormone. This does not prove that all the hormone remains inside the cell that makes it. Vitamin D and Intracrine Activity explains that distinction.

How does this connect with the rest of the body?

Local activity depends on available starting material and the cells’ surroundings. Meyer and colleagues detected active vitamin D outside the kidney in specially altered mice. Lee and colleagues found similar blood active-hormone levels in kidney-altered mice and controls. In the more affected model, parathyroid hormone, which helps control blood calcium, was higher and bone density was lower.

Similar blood levels therefore did not mean that all body measurements were normal. Some hormone might still have been made in the kidney, other tissues might have made it, or slower breakdown might have helped maintain the level. The studies did not measure how much each route contributed. The two mouse papers involved connected researchers and methods, rather than separate teams repeating one identical experiment. Tissue-Specific Vitamin D Metabolism explains the tissue-metabolism setting, while Where Vitamin D Acts describes the wider locations of vitamin D action.

What remains uncertain?

Human cells in a dish and altered mice answer different questions from supplement trials in people. Timing, protein binding and how cells were stimulated all matter. The findings do not show activity in every tissue, how much hormone moves through each human tissue over time, a general health benefit or a personal supplement dose.

Scientific sources

Availability of 25-hydroxyvitamin D(3) to APCs controls the balance between regulatory and inflammatory T cell responses. Jeffery LE, Wood AM, Qureshi OS, et al. Journal of immunology (Baltimore, Md. : 1950). 2012;189(11):5155-64. DOI: 10.4049/jimmunol.1200786.

Vitamin D-binding protein controls T cell responses to vitamin D. Kongsbak M, von Essen MR, Levring TB, et al. BMC immunology. 2014;15:35. DOI: 10.1186/s12865-014-0035-2.

Macrophages Control the Bioavailability of Vitamin D and Vitamin D-Regulated T Cell Responses. Lopez DV, Al-Jaberi FAH, Woetmann A, et al. Frontiers in immunology. 2021;12:722806. DOI: 10.3389/fimmu.2021.722806.

Autocrine vitamin D signaling switches off pro-inflammatory programs of TH1 cells. Chauss D, Freiwald T, McGregor R, et al. Nature immunology. 2022;23(1):62-74. DOI: 10.1038/s41590-021-01080-3.

Spatial detection and consequences of nonrenal calcitriol production as assessed by targeted mass spectrometry imaging. Meyer MB, Lee SM, Cichanski SR, et al. JCI insight. 2024;9(15). DOI: 10.1172/jci.insight.181763.

Kidney deletions of Cyp27b1 fail to reduce serum 1,25(OH)2D3. Lee SM, Cichanski SR, Pintozzi NG, et al. The Journal of steroid biochemistry and molecular biology. 2025;250:106734. DOI: 10.1016/j.jsbmb.2025.106734.

Related reading

Original sources

Source

Availability of 25-hydroxyvitamin D(3) to APCs controls the balance between regulatory and inflammatory T cell responses

Published in Jeffery LE, Wood AM, Qureshi OS, et al. Journal of immunology (Baltimore, Md. : 1950) (2012).

Publication details

Availability of 25-hydroxyvitamin D(3) to APCs controls the balance between regulatory and inflammatory T cell responses. Jeffery LE, Wood AM, Qureshi OS, et al. Journal of immunology (Baltimore, Md. : 1950). 2012;189(11):5155-64. DOI: 10.4049/jimmunol.1200786.

Read more →
Source

Vitamin D-binding protein controls T cell responses to vitamin D

In vitro studies have shown that the active form of vitamin D3, 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3), can regulate differentiation of CD4+ T cells by inhibiting Th1 and Th17 cell differentiation and promoting Th2 and Treg cell differentiation.

Publication details

Vitamin D-binding protein controls T cell responses to vitamin D. Kongsbak M, von Essen MR, Levring TB, et al. BMC immunology. 2014;15:35. DOI: 10.1186/s12865-014-0035-2.

Read more →
Source

Spatial detection and consequences of nonrenal calcitriol production as assessed by targeted mass spectrometry imaging

Here, utilizing on-tissue chemical derivatization and matrix assisted laser desorption ionization-mass spectrometry imaging (MALDI-MSI), we investigated the distribution of 1,25(OH)2D3 and 25(OH)D3 in the kidney, liver, spleen, and thymus.

Publication details

Spatial detection and consequences of nonrenal calcitriol production as assessed by targeted mass spectrometry imaging. Meyer MB, Lee SM, Cichanski SR, et al. JCI insight. 2024;9(15). DOI: 10.1172/jci.insight.181763.

Read more →
Source

Kidney deletions of Cyp27b1 fail to reduce serum 1,25(OH)2D3

Published in Lee SM, Cichanski SR, Pintozzi NG, et al. The Journal of steroid biochemistry and molecular biology (2025).

Publication details

Kidney deletions of Cyp27b1 fail to reduce serum 1,25(OH)2D3. Lee SM, Cichanski SR, Pintozzi NG, et al. The Journal of steroid biochemistry and molecular biology. 2025;250:106734. DOI: 10.1016/j.jsbmb.2025.106734.

Read more →